Patent Notices
Please see the following table for U.S. Patents covering Allergan Products.
The absence of a product name from this list or U.S. Patent number as associated with any listed product does not constitute a waiver of Allergan’s patent, trademark, or other intellectual property rights concerning that product.
The absence of a product name from this list or U.S. Patent number as associated with any listed product does not constitute a waiver of Allergan’s patent, trademark, or other intellectual property rights concerning that product.
| Product | Patent Number |
|---|---|
| ACTONEL® (risedronate sodium) tablets |
U.S. 6,165,513 U.S. 7,192,938 U.S. 7,718,634 |
| ACULAR LS® 0.4% (ketorolac tromethamine ophthalmic solution) |
U.S. 8,008,338 U.S. 8,207,215 U.S. 8,377,982 U.S. 8,541,463 U.S. 8,648,107 U.S. 8,906,950 U.S. 8,946,281 U.S. 9,216,167 |
| ACUVAIL® 0.45% (ketorolac tromethamine ophthalmic solution) |
U.S. 7,842,714 U.S. 8,512,717 U.S. 8,992,952 U.S. 9,192,571 |
| ALLODERM RTU™ | U.S. 8,735,054 |
| ALPHAGAN® P 0.1% & 0.15% (brimonidine tartrate ophthalmic solution) *Covers ALPHAGAN® P 0.1% only |
U.S. 6,562,873 U.S. 6,627,210 U.S. 6,641,834 U.S. 6,673,337 U.S. 8,858,961* U.S. 9,295,641 U.S. 9,687,443* |
| ASACOL® HD (mesalamine) delayed-release tablets, for oral use |
U.S. 6,893,662 U.S. 8,580,302 U.S. 9,089,492 |
| ATELVIA® (risedronate sodium) delayed-release tablets |
U.S. 7,645,459 U.S. 7,645,460 U.S. 8,246,989 |
| AVYCAZ® (ceftazidime and avibactam) for injection, for intravenous use |
U.S. 7,112,592 U.S. 7,612,087 U.S. 8,178,554 U.S. 8,471,025 U.S. 8,835,455 U.S. 8,969,566 U.S. 9,284,314 U.S. 9,695,122 |
| BOTOX® (OnabotulinumtoxinA) |
U.S. 8,501,195 U.S. 9,764,011 |
| BYSTOLIC® (nebivolol) tablets, for oral use |
U.S. 6,545,040 |
| BYVALSON® (nebivolol and valsartan) tablets, for oral use |
U.S. 7,803,838 U.S. 7,838,552 |
| CANASA® (mesalamine) rectal suppository |
U.S. 8,217,083 U.S. 8,436,051 |
| COMBIGAN® 0.2/0.5% (brimonidine tartrate/timolol maleate ophthalmic solution) |
U.S. 7,030,149 U.S. 7,320,976 U.S. 7,323,463 U.S. 7,642,258 U.S. 8,133,890 U.S. 8,354,409 U.S. 8,748,425 U.S. 9,474,751 U.S. 9,770,453 U.S. 9,907,801 U.S. 9,907,802 |
| COOLSCULPTING® | U.S. D568,258 S U.S. 7,367,341 U.S. 8,285,390 U.S. 8,523,927 U.S. 8,702,774 U.S. 8,834,547 U.S. 8,840,608 U.S. 9,132,031 U.S. 9,308,120 U.S. 9,375,345 U.S. D777,338 U.S. 9,358,149 U.S. 9,655,770 U.S. 9,861,421 U.S. 10,292,859 U.S. 10,524,956 |
| CYMETRA® MICRONIZED ALLODERM® | US 6,933,326 US 7,358,284 |
| DALVANCE® (dalbavancin) for injection, for intravenous use |
U.S. 6,900,175 U.S. 7,115,564 U.S. 7,119,061 U.S. 8,143,212 |
| DERMALINFUSION® | U.S. 6,695,853 U.S. 7,658,742 |
| DELZICOL® (mesalamine) delayed-release capsules, for oral use |
U.S. 6,649,180 |
| FETZIMA® (levomilnacipran) extended-release capsules, for oral use |
U.S. 8,481,598 U.S. 8,865,937 RE43879 |
| FOURTE® Expander Fill System | U.S. 10,433,928 |
| GELNIQUE® (oxybutynin chloride) 10% Topical Gel |
U.S. 7,029,694 U.S. 7,179,483 U.S. 8,241,662 U.S. 8,920,392 U.S. 9,259,388 U.S. 10,272,061 U.S. 10,449,173 |
| GENERESS® Fe (Norethindrone and Ethinyl Estradiol and Ferrous Fumarate) 0.025 MG; 0.8 MG tablets |
U.S. 6,667,050 |
| JUVÉDERM® XC | U.S. 8,357,795 U.S. 8,450,475 U.S. 8,822,676 U.S. 9,089,518 U.S. 9,089,519 U.S. 10,391,202 U.S. 10,485,896 U.S. D865,948 U.S. D865,949 U.S. D865,950 U.S. D866,753 U.S. D867,582 |
| JUVÉDERM® Ultra Plus XC | U.S. 8,357,795 U.S. 8,450,475 U.S. 8,822,676 U.S. 9,089,518 U.S. 9,089,519 U.S. 10,391,202 U.S. 10,485,896 U.S. D865,948 U.S. D865,949 U.S. D865,950 U.S. D866,753 U.S. D867,582 |
| JUVÉDERM® Ultra XC | U.S. 8,357,795 U.S. 8,450,475 U.S. 8,822,676 U.S. 9,089,518 U.S. 9,089,519 U.S. 10,391,202 U.S. 10,485,896 U.S. D865,948 U.S. D865,949 U.S. D865,950 U.S. D866,753 U.S. D867,582 |
| JUVÉDERM VOLBELLA® XC | U.S. 7,741,476 U.S. 8,357,795 U.S. 8,450,475 U.S. 8,822,676 U.S. 9,089,517 U.S. 9,089,518 U.S. 9,089,519 US 10,080,767 U.S. 10,391,202 U.S. 10,485,896 U.S. D865,948 U.S. D865,949 U.S. D865,950 U.S. D866,753 U.S. D867,582 |
| JUVÉDERM VOLLURE™ XC | U.S. 7,741,476 U.S. 8,357,795 U.S. 8,450,475 U.S. 8,822,676 U.S. 9,089,517 U.S. 9,089,518 U.S. 9,089,519 US 10,080,767 U.S. 10,391,202 U.S. 10,485,896 U.S. D865,948 U.S. D865,949 U.S. D865,950 U.S. D866,753 U.S. D867,582 |
| JUVÉDERM VOLUMA® | U.S. 6,921,819 U.S. 7,741,476 U.S. 8,357,795 U.S. 8,822,676 U.S. 9,089,517 U.S. 9,089,518 U.S. 9,089,519 U.S. 10,080,767 U.S. 10,485,896 U.S. D865,948 U.S. D865,949 U.S. D865,950 U.S. D866,753 U.S. D867,582 |
| KELLER FUNNEL® (Silicone Breast Implant Sleeve) | U.S. 8,211,173 U.S. 8,550,090 U.S. 8,555,893 U.S. 9,402,713 U.S. 10,213,294 U.S. 10,463,472 |
| KYBELLA® (deoxycholic acid) injection, for subcutaneous use |
U.S. 7,622,130 U.S. 7,754,230 U.S. 8,101,593 U.S. 8,242,294 U.S. 8,298,556 U.S. 8,367,649 U.S. 8,461,140 U.S. 8,546,367 U.S. 8,653,058 U.S. 8,846,066 U.S. 8,883,770 U.S. 9,522,155 U.S. 9,636,349 U.S. 9,949,986 U.S. 10,500,214 |
| LASTACAFT® 0.25% (alcaftadine ophthalmic solution) |
U.S. 8,664,215 |
| LATISSE® (bimatoprost ophthalmic solution) |
U.S. 8,038,988 U.S. 8,101,161 U.S. 8,263,054 U.S. 8,541,466 U.S. 8,632,760 U.S. 8,758,733 U.S. 8,906,962 U.S. 8,986,715 U.S. 9,216,183 U.S. 9,226,931 U.S. 9,579,270 |
| LEXAPRO® (escitalopram oxalate) Tablets, LEXAPRO® (escitalopram oxalate) Oral Solution |
U.S. 6,916,941 U.S. 7,420,069 |
| LINZESS® (linaclotide) capsules, for oral use |
U.S. 7,304,036 U.S. 7,371,727 U.S. 7,704,947 U.S. 7,745,409 U.S. 8,080,526 U.S. 8,110,553 U.S. 8,748,573 U.S. 8,802,628 U.S. 8,933,030 U.S. 9,708,371 |
| LO LOESTRIN® FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) |
U.S. 7,704,984 |
| LUMIGAN® 0.01% (bimatoprost ophthalmic solution) |
U.S. 7,851,504 U.S. 8,338,479 U.S. 8,278,353 U.S. 8,299,118 U.S. 8,309,605 U.S. 8,524,777 U.S. 8,586,630 U.S. 8,772,338 U.S. 8,933,120 U.S. 8,933,127 U.S. 9,155,716 U.S. 9,241,918 |
| LYTERA™ Skin Brightening Complex | U.S. 8,236,288 U.S. 8,778,315 U.S. 8,865,138 |
| MINASTRIN®24 FE | U.S. 6,667,050 U.S. 7,704,984 |
| NAMENDA XR® (memantine hydrochloride) extended release capsules, for oral use |
U.S. 8,039,009 U.S. 8,168,209 U.S. 8,173,708 U.S. 8,283,379 U.S. 8,329,752 U.S. 8,362,085 |
| NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use |
U.S. 8,039,009 U.S. 8,058,291 U.S. 8,168,209 U.S. 8,173,708 U.S. 8,283,379 U.S. 8,293,794 U.S. 8,329,752 U.S. 8,338,485 U.S. 8,338,486 U.S. 8,362,085 U.S. 8,580,858 U.S. 8,598,233 |
| OCUMEND® | U.S. 10,022,335 |
| OPTIVE® Advanced | U.S. 9,314,528 U.S. 8,569,367 U.S. 8,569,370 U.S. 8,729,125 U.S. 8,957,048 U.S. 9,254,324 U.S. 9,314,528 U.S. 9,821,020 U.S. 9,907,826 U.S. 10,105,386 |
| OPTIVE® Fusion UD | U.S. 8,569,370 U.S. 8,729,125 U.S. 9,254,324 U.S. 8,569,367 U.S. 8,569,370 U.S. 8,729,125 U.S. 9,254,324 U.S. 9,821,020 U.S. 9,668,997 U.S. 10,213,405 |
| OZURDEX® (dexamethasone intravitreal implant) |
U.S. 6,726,918 U.S. 6,899,717 U.S. 7,033,605 U.S. 7,767,223 U.S. 8,034,366 U.S. 8,034,370 U.S. 8,043,628 U.S. 8,063,031 U.S. 8,088,407 U.S. 8,506,987 U.S. 9,012,437 U.S. 9,192,511 U.S. 9,283,178 |
| REDNESS RELIEF CALMPLEX® | U.S. 8,246,969 U.S. 8,246,971 U.S. 8,268,336 U.S. 8,496,951 U.S. 9,107,874 |
| REFRESH OPTIVE® 0.5% & 0.9% (Lubricant eye drops) |
U.S. 8,569,367 U.S. 8,569,370 U.S. 8,729,125 U.S. 9,254,324 |
| REFRESH OPTIVE MEGA-3® | U.S. 8,569,367 U.S. 8,569,370 U.S. 8,679,554 U.S. 8,729,125 U.S. 9,254,324 U.S. 9,821,020 U.S. 10,279,005 |
| REFRESH RELIEVA™ | U.S. 10,213,405 |
| REFRESH RELIEVA™ PF | U.S. 8,569,367 U.S. 8,569,370 U.S. 8,729,125 U.S. 9,254,324 U.S. 9,821,020 U.S. 9,668,997 U.S. 10,213,405 |
| RESTASIS® 0.05% (cyclosporine ophthalmic emulsion) |
U.S. 8,629,111 U.S. 8,633,162 U.S. 8,642,556 U.S. 8,648,048 U.S. 8,685,930 U.S. 9,248,191 |
| RESTASIS® Multidose (Cyclosporine Ophthalmic Emulsion) 0.05% |
U.S. 8,629,111 U.S. 8,633,162 U.S. 8,642,556 U.S. 8,648,048 U.S. 8,685,930 U.S. 9,248,191 U.S. 8,292,129 U.S. 8,561,859 U.S. 9,669,974 U.S. 9,676,525 |
| REVOLVE® | U.S. 9,296,984 |
| SAPHRIS® (asenapine) sublingual tablets |
U.S. 5,763,476 U.S. 7,741,358 U.S. 8,022,228 |
| SARAFEM® (Fluoxetene hydrochloride) |
U.S. 6,960,577 |
| SAVELLA® (milnacipran HCl) Tablets |
U.S. 6,602,911 U.S. 6,922,110 U.S. 7,888,342 U.S. 7,994,220 |
| SCAR RECOVERY GEL WITH CENTELLINE® | U.S. 8,071,139 U.S. 8,591,961 |
| STRATTICE® | U.S. 8,735,054 |
| STRATTICE® Perforated | U.S. 8,735,054 U.S. 10,537,665 |
| TEFLARO® (ceftaroline fosamil) for injection, for intravenous use |
U.S. 6,417,175 U.S. 6,906,055 U.S. 7,419,973 U.S. 8,247,400 U.S. 9,629,861 |
| TRUETEAR® (neurostimulator device) | U.S. 8,996,137 U.S. 9,440,065 U.S. 9,770,583 U.S. 9,956,397 U.S. 9,687,652 U.S. 10,155,108 U.S. D837,396 |
| VIBERZI® (eluxadoline) tablets, for oral use, CIV |
U.S. 7,741,356 U.S. 7,786,158 U.S. 8,344,011 U.S. 8,609,709 U.S. 8,691,860 U.S. 8,772,325 U.S. 9,115,091 U.S. 9,205,076 U.S. 9,364,489 U.S. 9,675,587 U.S. 9,700,542 U.S. 9,789,125 U.S. 10,188,632 U.S. 10,213,415 |
| VIIBRYD® (vilazodone hydrochloride) tablets, for oral use |
U.S. 7,834,020 U.S. 8,193,195 U.S. 8,236,804 U.S. 8,673,921 |
| VRAYLAR® (cariprazine) capsules, for oral use |
U.S. 7,737,142 U.S. 7,943,621 U.S. RE47350 |
| UBRELVY™ | U.S. 8,912,210 U.S. 9,833,448 U.S. 9,499,545 U.S. 8,754,096 U.S. 10,117,836 |
| ZENPEP® (pancrelipase) delayed release capsules |
U.S. 7,658,918 U.S. 8,221,747 U.S. 8,246,950 U.S. 8,562,978 U.S. 8,562,979 U.S. 8,562,980 U.S. 8,562,981 U.S. 10,206,882 |
| ZYMAR® 0.3% (gatifloxacin ophthalmic solution) |
U.S. 6,333,045 |